Production (Stage)
Oragenics, Inc.
OGEN
$4.28
$0.7521.25%
AMEX
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 3.42M | 864.80K | 3.14M | 1.35M | 2.07M |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 239.90K | 430.20K | 583.30K | 22.00K | 134.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 208.10K | 177.40K | 386.00K | 248.30K | 237.20K |
Total Current Assets | 3.87M | 1.47M | 4.11M | 1.62M | 2.44M |
|
|||||
Total Current Assets | 3.87M | 1.47M | 4.11M | 1.62M | 2.44M |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | 1.09M | 1.09M | 1.09M |
Total Assets | 3.87M | 1.47M | 5.20M | 2.71M | 3.53M |
|
|||||
Total Accounts Payable | 772.50K | 1.14M | 1.51M | 1.18M | 695.80K |
Total Accrued Expenses | 404.50K | 211.20K | 93.80K | 202.90K | 86.10K |
Short-term Debt | 2.55M | 328.50K | 519.40K | -- | 126.80K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 3.73M | 1.68M | 2.13M | 1.38M | 908.70K |
|
|||||
Total Current Liabilities | 3.73M | 1.68M | 2.13M | 1.38M | 908.70K |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 2.55M | 328.50K | 519.40K | -- | 126.80K |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 3.73M | 1.68M | 2.13M | 1.38M | 908.70K |
|
|||||
Common Stock & APIC | 219.14M | 216.57M | 214.92M | 210.71M | 209.70M |
Retained Earnings | -219.00M | -216.79M | -213.44M | -210.97M | -208.67M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 137.70K | -211.90K | 1.48M | -266.30K | 1.03M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | 1.59M | 1.59M | 1.59M |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | 1.59M | 1.59M | 1.59M |
|
|||||
Total Common Equity | 137.70K | -211.90K | 1.48M | -266.30K | 1.03M |
Total Preferred Equity | -- | -- | 1.59M | 1.59M | 1.59M |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 137.70K | -211.90K | 3.08M | 1.33M | 2.63M |
|